Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 7
1986 12
1987 13
1988 3
1989 10
1990 10
1991 7
1992 15
1993 10
1994 8
1995 7
1996 2
1997 3
1998 3
1999 3
2000 7
2002 5
2003 6
2004 4
2005 6
2006 4
2008 2
2009 4
2010 4
2011 3
2012 3
2013 2
2014 1
2015 4
2016 4
2017 2
2018 2
2019 2
2020 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

174 results
Results by year
Filters applied: . Clear all
Page 1
Functional and Phenotypic Characteristics of Human Leptin Receptor Mutations.
Nunziata A, Funcke JB, Borck G, von Schnurbein J, Brandt S, Lennerz B, Moepps B, Gierschik P, Fischer-Posovszky P, Wabitsch M. Nunziata A, et al. Among authors: gierschik p. J Endocr Soc. 2018 Sep 17;3(1):27-41. doi: 10.1210/js.2018-00123. eCollection 2019 Jan 1. J Endocr Soc. 2018. PMID: 30560226 Free PMC article. Review.
PH domains and phospholipases--a meaningful relationship?
Parker PJ, Hemmings BA, Gierschik P. Parker PJ, et al. Among authors: gierschik p. Trends Biochem Sci. 1994 Feb;19(2):54-5. doi: 10.1016/0968-0004(94)90031-0. Trends Biochem Sci. 1994. PMID: 8160264 Review. No abstract available.
Discovery and characterization of an endogenous CXCR4 antagonist.
Zirafi O, Kim KA, Ständker L, Mohr KB, Sauter D, Heigele A, Kluge SF, Wiercinska E, Chudziak D, Richter R, Moepps B, Gierschik P, Vas V, Geiger H, Lamla M, Weil T, Burster T, Zgraja A, Daubeuf F, Frossard N, Hachet-Haas M, Heunisch F, Reichetzeder C, Galzi JL, Pérez-Castells J, Canales-Mayordomo A, Jiménez-Barbero J, Giménez-Gallego G, Schneider M, Shorter J, Telenti A, Hocher B, Forssmann WG, Bonig H, Kirchhoff F, Münch J. Zirafi O, et al. Among authors: gierschik p. Cell Rep. 2015 May 5;11(5):737-47. doi: 10.1016/j.celrep.2015.03.061. Epub 2015 Apr 23. Cell Rep. 2015. PMID: 25921529 Free article.
Noncatalytic Bruton's tyrosine kinase activates PLCγ2 variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells.
Wist M, Meier L, Gutman O, Haas J, Endres S, Zhou Y, Rösler R, Wiese S, Stilgenbauer S, Hobeika E, Henis YI, Gierschik P, Walliser C. Wist M, et al. Among authors: gierschik p. J Biol Chem. 2020 Apr 24;295(17):5717-5736. doi: 10.1074/jbc.RA119.011946. Epub 2020 Mar 17. J Biol Chem. 2020. PMID: 32184360 Free PMC article.
Activated PLCγ breaking loose.
Gierschik P, Buehler A, Walliser C. Gierschik P, et al. Structure. 2012 Dec 5;20(12):1989-90. doi: 10.1016/j.str.2012.11.009. Structure. 2012. PMID: 23217678 Free article.
Estimated prevalence of potentially damaging variants in the leptin gene.
Nunziata A, Borck G, Funcke JB, Kohlsdorf K, Brandt S, Hinney A, Moepps B, Gierschik P, Debatin KM, Fischer-Posovszky P, Wabitsch M. Nunziata A, et al. Among authors: gierschik p. Mol Cell Pediatr. 2017 Nov 3;4(1):10. doi: 10.1186/s40348-017-0074-x. Mol Cell Pediatr. 2017. PMID: 29101506 Free PMC article.
174 results